Sunday, February 23, 2025
Health
At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
Only in the crazy sector of metabolic medicines can 32% revenue growth be considered a disappointment. That’s how much Eli...
Prioritize Provider Data for Seamless M&A Success
When it comes to mergers and acquisitions (M&As), they tend to mesh in one of two ways: Oil and water...
Why Hospitals’ Revenue Growth Is Likely to Slow Down in 2025
Healthcare providers’ operating margins declined in November due to lower patient demand levels and persistent increases in expenses, according to...
Past Presidents Posthumous Advice To Trump #47
By MIKE MAGEE For those many, many millions of viewers who tuned in to the live coverage of former President...
How big is the 2025 Medicare rate cut for physicians?
At the end of last year, CMS finalized a rate cut for Medicare reimbursement to...
Innovaccer Rakes In $275M, Kicking Off What Will Likely Be Another Hot Year for AI Funding
Investors predicted that 2025 would be a big year for healthcare AI fundraising, and this forecast already seems to be...
Life sciences companies falling behind?
That is what an analysis from PwC finds, at least with respect to stock market...
Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More
A case can be made that metabolic medicine was the theme of the life sciences industry in 2024. Insatiable market...
You, Me, and Our Microbiome
By KIM BELLARD You may have heard about the microbiome, that collection of microorganisms that fill the world around, and...
Going once, going twice…Open Enrollment ends soon!
Time’s almost up to get health coverage for 2025. Act before January 15 to enroll in health coverage that starts...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.